---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-052778"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2022-04-29T23:59:59+00:00"
generated_at: "2026-06-26T02:30:44.977108+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# iRadimed Q1 revenue $12.3M (+33% YoY), EPS $0.20; raises FY22 guidance

## Summary
- Q1 revenue $12.3M vs $9.2M YoY; GAAP diluted EPS $0.20 vs $0.11; non-GAAP EPS $0.22 vs $0.13.
- Raised FY22 guidance: revenue $52.5-53.2M (prev $51.4-52.2M), GAAP EPS $0.89-0.95, non-GAAP EPS $0.96-1.03.
- Q2 guidance: revenue $12.5-12.7M, GAAP EPS $0.21-0.23, non-GAAP EPS $0.23-0.25.
- Paid special dividend of $1.00 per share during Q1 2022; monitors segment revenue surged to $5.19M from $2.60M YoY.

## SEC filing metadata
- accession: 0001104659-22-052778
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2022-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000110465922052778/0001104659-22-052778-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000110465922052778/tm2213916d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-052778
- JSON: https://secwatch.observer/filing/0001104659-22-052778.json
- Plain text: https://secwatch.observer/filing/0001104659-22-052778.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.